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ABSTRACT
The purpose of this study was to examine if anxiety diagnoses were associated
with increased risk for suicidality and to examine if comorbid anxiety and depression
diagnoses have a synergistic effect on suicidality. In a sub-analysis, we assessed
associations between anxiety and/or depression symptoms (versus diagnoses) with
suicidality in order to inform a future study.
Completed at the Burlingame Center for Psychiatric Research and Education at
the Institute of Living (IOL) in Hartford, CT, this quantitative, cross-sectional study
involved 20,823 adult inpatients admitted for psychiatric care from 2000-2009. Estimates
of effects calculated were odds ratios (ORs) qualified at 95% confidence intervals (CIs).
Descriptive, bivariate, and stratified statistics were utilized in the study. Through analysis
of two-way interactions, we judged evidence of synergism or antagonism. Finally, we
constructed binary logistic regression models to assess the anxiety - suicidality
association.
We found that anxiety and depression diagnoses were associated with
approximately 40% and 160% increased risk of suicidality after controlling for
demographic and clinical confounders. Furthermore, our analysis provided evidence that

the effects on risk of suicidality of these two diagnostic groups were independent, neither
synergistic nor antagonistic in this population. Preliminary analyses suggest that anxiety
symptom information may be a better predictor of suicidality than the presence of a
DSM-IV diagnosis. Additional research is warranted to examine the nature of anxiety
symptoms that precede suicidal behaviors and to examine if symptom clusters work
synergistically to increase suicidal risk as well as what symptom clusters present the
greatest suicidal risk.
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CHAPTER I
INTRODUCTION
Scope of the Problem
Suicidality is a global concern. In fact, on September 10, 2009, during the World
Suicide Prevention Day, Mishara stated:
We live in a world where the media bombards us daily with stories of violent deaths
occurring in the context of wars, terrorist attacks and homicides. Yet, worldwide each
year, more human beings kill themselves than are killed in all wars, terrorist attacks
and homicides combined. (p. 1)
The World Health Organization (2008) estimates that every 40 seconds someone in the world
dies by suicide, which adds up to 1 million suicides across the world each year. The National
Institute of Mental Health (NIMH) (2009), using data from the Center for Disease Control
(CDC), reported that in 2006 suicide was the eleventh leading cause of death in the United
States. In that year, the incidence of suicide was 10.9 per every 100,000 people, amounting to
33,000 deaths in the US alone.
Table 1. Number of Suicides by Age in the United States in 2006
(Adapted from Heron et al., 2009.)

Population by age in years Number of deaths by Suicide
5-14
15-24
25-34
35-44
45-54
55-64
65-74
75-84
85 and over
Not stated

219
4,189
4,985
6,591
7,426
4,583
2,384
2,075
840
8
33,000

Total
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Astoundingly, for every suicide death the NIMH (2009) estimates that there are 12-25
nonfatal suicide attempts, accounting for as many as 825,000 attempts per year in the U.S., a
rate of approximately one for every 37 citizens. When you factor in the number of attempts
and the number of people plagued by suicidal ideation, the toll in human suffering is
immeasurable. The problem has become of such importance that suicide prevention has been
identified as a national and world imperative by the Institute of Medicine National
Academies (Goldsmith, Pellmar, Kleinman, & Bunney, 2002), the U.S. Surgeon General
(U.S. Public Health Service, 1999), and the World Health Organization (2008).
Predicting Suicidality
The relationship between psychiatric illness and suicidality has been discussed
frequently in the psychosocial literature. (Suicidality is defined herein as the range of suicidal
behaviors including ideation, attempts, and completed suicide.) In fact, diagnoses and
incidence of suicidality have been studied in the past to determine if certain psychiatric
diagnoses carry a higher risk for suicidal behaviors (Bernal et al., 2007; Nock et al., 2008),
and some differences have been noted. However, despite the plethora of research available,
much is still unclear about the exact components of mental illness that lead to suicidality. The
fact that, compared to the risk of suicidality in the general population, the risk is elevated
across individuals with psychiatric diagnoses suggests that a common element or elements in
individuals with these diagnoses may be the root cause(s) of suicidality among mental health
patients. Psychiatric disorders often share the same symptom(s) in their diagnostic profiles,
although the prevalence of these symptoms may vary by diagnosis. Thus if a symptom or
symptoms and not diagnoses are causative for suicidality, the variation in prevalence of
2

symptoms may explain why the risk for suicidal behaviors differs between psychiatric
diagnoses. Isolating the exact components that are predictive of suicidal behavior is
important for accurate assessment (in terms of sensitivity and specificity for the prediction of
suicidality) and treatment. For example, because suicide attempts can occur in the absence of
mental illness and can occur across a variety of diagnoses, suicidal risk cannot be based on
current definitions of diagnoses alone. Although postmortem studies have indicated that 90%
of all people who commit suicide have a psychiatric disorder (Yan, 2009), the World Health
Organization (WHO) found that mental illness was prevalent in only 65.7% of suicide
attempters in developed countries and 54.6% in developing countries (Nock et al., 2009).
Furthermore, when looking at the diagnosis of depression, Yan (2009) underscored that in
the multi-national study conducted by WHO, researchers found that although depression was
strongly associated with suicidal ideation, it was not predictive of suicide attempts. This is a
strong departure from conventional wisdom and the findings of many studies, and raises
questions about the assumed necessary role of depression in the progression of suicidality
(Nock et al., 2009). In fact, the WHO found that the only commonalities across diagnoses in
both developed and developing countries that were predictive of the transition from suicidal
ideation to suicidal attempts were anxiety symptoms and impulsivity (Nock et al., 2009).
An argument could be made for reformulating diagnostic criteria and taxonomy to
better differentiate and screen disorders that also present with symptoms of anxiety and/or
impulsivity. In light of the importance of comorbid mood disorders and anxiety, an affect
disorder workgroup from the American Psychiatric Association is even debating whether to
add a new diagnostic category called “Anxious Depression or Mixed Anxiety-Depression”
(Fawcett, 2009) for the Diagnostic and Statistical Manual of Mental Disorders, 5th edition
3

(DSM-V) that will be published in 2012. The workgroup is also discussing whether to add a
dimensional aspect to mood disorders in general that would assess severity across various
symptom variables and/or whether anxious depression should be listed as a separate
diagnosis. However, an important consideration is that symptoms of anxiety that do not meet
the full criteria to warrant an anxiety diagnosis still may have important implications in
suicidal assessment, particularly in patients with depression (Diefenbach, Woolley, &
Goethe, 2009). Furthermore, although a change in diagnostics may help inform clinical
practice and treatment plan development, the changes in diagnoses alone may not be the most
effective way to promote understanding of the development and prediction of suicidality.
Suicide has been associated with multiple environmental/social and psychological
causal pathways. Environmental/social triggers include major life events such as loss of
loved ones, social isolation and employment problems. In the psychological arena, early
psychoanalytic theory proposed that suicide is aggression or hatred turned inward against
one’s self (Gonda, Fountoulakis, Kaprinis, & Rihmer, 2007; Joiner, 2005). Multiple other
psychological theories have been developed since then including theories about hopelessness
(Gonda et al., 2007) or about what Shneidman termed “psychache” or “psychological pain”
being the root of suicidality (Joiner, 2005). More recent theories include Linehan’s
biopsychosocial model that indicates that a biological predisposition, an oversensitive
temperament, an invalidating environment and/or trauma work to contribute to an inability to
regulate emotions (Joiner, 2005). This emotional dysregulation can result in self-injury or
suicidal behaviors.
Although affective, anxiety, and impulse control disorders have each been
investigated independently as predictors of suicidality, formal research is needed to consider
4

potential synergistic effects of the disorders. To address this issues, the study described
herein considered the elements of the development of suicidality suggested in the literature
described above by examining the crude associations of anxiety and of depression, (as
diagnoses), independently and in combination with suicidality in a population of adult
psychiatric patients treated in a community hospital. Ultimately, the purpose of this study
was to explore in depth the mechanisms underlying suicidal ideation and suicide attempts by
examining the joint effect of anxiety and depression in order to enhance risk assessment.
Obviously, the relevance of the study to clinical practice is the impact that it will have on
assessment of suicidality, treatment, and follow-up care.

Relevance to Social Work
The relevance of this research to social work is that it may support better outcomes
for suicidal people by providing information that can inform screening protocols for
suicidality and by informing therapeutic interventions. For example, if depression with cooccurring anxiety causes an increase in suicidality that exceeds the sum of the individual
effects of these other two conditions, therapeutic techniques and medications can be
structured aggressively around targeted symptom combinations to reduce their effects. Also,
being able to predict if patients are at an elevated risk of suicidality can help determine the
level of care appropriate to ensure patient safety and to determine the type of safety plans that
are needed. Understanding the mechanisms behind suicidal behaviors in advance of
completed suicides will provide information that may provide clarity about effective steps in
improving outcomes of treatment by stopping suicidal ideation and attempts from escalating
to completed suicides. Thus, by utilizing evidence-based research in treatment not only is
5

patient care improved, but the professional credibility of social workers is enhanced. More
importantly, working on reducing human suffering and improving quality of life, which in
turn promotes social justice, is in keeping with the National Association of Social Worker’s
Code of Ethics (2008).
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CHAPTER II
LITERATURE REVIEW
Previous authors have noted that identifying and determining how certain factors
synergistically foster suicidal behaviors and the process that leads from suicidal ideation to
completed suicide is complex and still unknown. For example, Goldsmith, Pellmar,
Kleinman, and Bunney (2002) reported:
Despite the extensive knowledge that research has provided regarding these
[suicidal] risk and protective factors, we are still far from being able to
integrate these factors so as to understand how they work in concert to evoke
suicidal behavior or to prevent it. (p. 3)
A review of previous research shows that the relationship of suicidality with anxiety
disorders is confusing in part because of the many forms of these disorders including
posttraumatic stress disorder (PTSD), panic disorder (PD), and generalized anxiety disorder
(GAD). Researchers, at present, do not agree on the form(s) of anxiety disorder that is/are
most associated with suicidality.
For example, Diaconu and Turecki (2007) conducted a cross-sectional study
exploring panic disorder, major depressive disorder, and suicidality among 474 outpatient
psychiatric subjects. The authors concluded that panic disorder was associated only with
suicidal behavior if the patient had comorbid depression. By comparing suicidal behavior
across three groups consisting of a panic disorder with comorbid depression group, a
depressive disorders group, and a panic disorders alone group, Diaconu and Turecki
concluded that the increase in suicidality was attributed to comorbid depressive disorder.
7

Because there was little difference in terms of increased risk for suicidal behavior between
both the depressive disorders group and the panic disorder with comorbid depression group,
they concluded that underlying depressive disorder was the critical indicator for suicidal
behaviors. The weakness in this study was a relatively small sample size (78) of patients with
panic disorder. A further limit to the study was its inability in allowing the researchers to
evaluate a participant’s suicidality during an active panic attack or across time. Depending on
which comorbid disorders were controlled for, other studies resulted in different conclusions
about the relationship between panic disorder and suicidality (Vickers & McNally, 2004;
Nock et al., 2009; Beautrais et al., 1996).
Diaconu and Turecki’s (2007) evidence that underlying depression and not panic
disorder is the key indicator for suicidality, contrasts dramatically with the recent World
Health Organization’s (Nock et al., 2009) cross-national analysis which involved a much
larger sample size. In various nations, the presence (versus absence) of panic disorder was an
independent, significant predictor of suicide attempts (ORs = 2.3-3.0) (not just suicidal
ideation), after rigorously controlling for various comorbid disorders.
The analysis of the National Comorbidity Survey replication (NCS-R) by Cougle,
Keough, Riccardi, and Sachs-Ericsson (2009) had yet different findings that indicated panic
disorder was only significantly associated with suicidal ideation and not predictive for
suicide attempts. In addition, in this study, findings suggested that anxiety disorders in
general, independent of depression and other psychiatric conditions, were significantly
correlated with suicidal behavior. This two-step study evaluated English-speaking
participants from the contiguous United States, and in the first interview identified those
individuals who met the criteria of having a lifetime diagnosis of anxiety disorder and a
8

comparison group that was representative of those without a diagnosis of anxiety disorder.
This subsample included 4,131 participants who completed the second interview providing
information regarding lifetime suicidal ideation and suicide attempts. Specifically, after
controlling for other psychiatric conditions and demographic variables, the study found that
the presence (versus absence) of social anxiety disorder (SAD), posttraumatic stress disorder
(PTSD), generalized anxiety disorders (GAD), as well as panic disorder (PD) predicted
suicidal ideation, whereas among these anxiety disorders only the presence of SAD, PTSD,
and GAD predicted suicide attempts (Cougle et al., 2009). A hypothesis based on the
investigators’ findings is that anxiety may cause severe distress in patients, especially if the
anxiety is severe, so that assessing for suicidality is warranted when patients appear to be
severely anxious.
In contrast to Cougle et al.’s (2009) findings, Sareen, Houlahan, Cox, and
Asmundson (2009), examining a large nationally representative sample of 5,877 participants
ranging in age from 15-54 years (82.4% response rate), found PTSD to be the only anxiety
disorder statistically significantly associated with suicidal ideation and attempts. Other
anxiety disorders examined included lifetime social phobia, PD, agoraphobia, and GAD.
Using multivariate analyses controlling for demographics, PTSD was associated with a
nearly three-fold increased risk of ideation and of attempts. The validity of these results is
supported by the study’s use of a scale to establish diagnoses (the Composite International
Diagnostic Interview).
Interpreting the research results about anxiety’s role in suicidality discussed above, in
light of additional study findings, suggests that symptoms of anxiety are likely to be critical
factors in suicidality even in the absence of a specific anxiety diagnosis. Support for this
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thesis was found in a study conducted by Diefenback, Woolley, and Goethe (2009) at a major
psychiatric facility. A cross-sectional analysis examined 2,778 outpatients’ psychiatric
diagnoses established by unstructured clinical interviews. Outpatients also self-reported on
their symptoms including difficulties with anxiety (defined here as experiencing fear, anxiety
or panic) and with suicidal thoughts and behaviors on a standardized self-report questionnaire
completed upon admission. Presence (versus absence) of anxiety symptoms was associated
with a two-fold increase in the likelihood of suicidality, after controlling for potential
confounding by anxiety disorders, depressive disorders, symptoms of depression, and
demographics. However, this study may be limited because the psychiatric interviews
establishing diagnoses were unstructured and generalizability to other clinic populations
might have been limited because the sample consisted only of people receiving outpatient
care.
Previous research, including the studies discussed above, considered as a whole
strongly suggests an independent role of anxiety disorders (and perhaps of anxiety symptoms
alone) in the development of suicidality, although the studies contain methodological
limitations including the approaches to measuring psychiatric conditions, cross-sectional
study designs, and sampling that may have affected the generalizability of findings. For
example, Bongiovi-Garcia et al. (2009) conducted a study assessing how the use of
unstructured psychiatric interviews could impact the accuracy of the assessment of patient
suicidal ideation. In this study, postgraduate year II physicians (PGYII) supervised by an
attending psychiatrist completed unstructured assessments of 201 adult inpatients diagnosed
with either major depressive disorder or bipolar disorder (based on the DSM III-R, 1987,
third edition revised), and the results were compared to assessments by structured interviews
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conducted by master’s or Ph.D. level clinicians. Bongiovi-Garcia et al. found that 29.7% of
patients identified by a structured interview as having suicidal ideation were not diagnosed
accurately by the PGYIIs. A potential bias in the study, however, was that clinicians
administering both structured and unstructured interviews were not blind to the purposes of
the study. Despite this limitation the study demonstrates how suicidal ideation may be
underrepresented in clinical diagnosis, which represent the diagnoses in the majority of
studies on psychiatric diagnoses and suicidality.
Bongiovi-Garcia et al.’s (2009) study demonstrates one way that methodology can
influence the results of a study. As is often a limitation throughout psychiatric research,
designing a study to measure the actual state of mind of the patient, i.e., the true nature and
severity of psychiatric morbidity, is the most obvious challenge, and it is also difficult to
identify the events or circumstances leading to suicidal behaviors. However, this problem can
be lessened in research directed toward identifying predictors instead of the causal
mechanism for suicidality. In this sense, if what a patient reports, true or false, helps predict
suicidality, it is clinically useful. Similarly, if an unstructured approach to establish diagnoses
is used, and the diagnoses thus replicate those likely available in clinical settings, such
diagnoses could be useful predictors of suicidality. In this way, the true challenge of research
is to identify the information that most specifically predicts suicidality.
In an interview with Yan (2009), Nock noted that that future studies are being
proposed to examine “symptom clusters” because approximately 52% of the people who had
considered suicide seriously (which referred to ideation and not attempts in this study) in
developed countries and 43% in undeveloped countries, did not report a prior lifetime DSMIV diagnosis (Nock et al., 2009). This new focus on symptoms alone requires researchers not
11

only to identify symptoms that are associated with suicidality, but to consider carefully the
potential usefulness of sets of factors not necessarily individually associated with suicidality
in future studies.
Additionally, many previous studies were cross-sectional studies and often involve a
retrospective self-report of lifetime occurrences of events, emotions and feelings.
Retrospective self-reports are susceptible to recall bias, particularly as this type of psychiatric
research requires that patients self-report about personal, traumatic, and unpleasant events.
However, because many traumas are major life events, recall bias may be less of a limitation
when patients are asked yes/no questions. Nonetheless, establishing the chronology of events
is a necessary factor to support associations as either suggesting cause or as useful for
prediction to support interventions. Remembering the sequence of major events in one’s life,
unless they were perceived to be related, is likely to have biased some past studies.
The study described herein differs from prior research in a variety of ways. The study
enables a cross-sectional analysis of the synergistic effects of anxiety and depression
diagnoses on the risk of suicidality after controlling for other diagnoses,
psychopharmacology treatment, and demographics. Examining anxiety and depressive
diagnoses together will advance the literature by estimating anxiety diagnoses’ value in
predicting suicidality, independent of the effects of a depression diagnosis and controlling for
other potential risk factors. In addition, this study serves to inform an upcoming longitudinal
research project that will examine the associations between diagnoses, symptoms, and
perhaps symptom clusters with subsequent suicidality. The premise we are exploring is that
co-occurring anxiety and depressive symptoms versus comorbid anxiety and depression
diagnoses will be more predictive of suicidality. Furthermore, interviews with patients during
12

the upcoming project will allow for comprehensive examination of symptoms and clusters of
symptoms. In this way, the current thesis informs the design of the second study by providing
an in-depth examination of the anxiety-suicidality association. Such an examination may be
useful in planning clinical intervention. Although there have been multiple studies on
suicidal behavior, accurately predicting patient risk for suicidal behaviors is still difficult.
Demonstrating the need for continued research the WHO (Nock et al., 2009), after
conducting a multinational study involving 108,664 participants from 21 countries, recently
remarked, “A crucial goal for future research is to better understand how and why such a
diverse range of disorders are uniquely associated with suicide attempts” (p.13).
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CHAPTER III
METHODOLOGY
Research
The question we are examining is if an anxiety diagnosis is in fact predictive of
suicidality in an adult psychiatric inpatient population. If anxiety is predictive of suicidality,
does comorbidity with depression have a synergistic effect causing an even greater risk for
suicidality than the additive risks of having depression symptoms alone or anxiety symptoms
alone? The hypotheses, tested in a cross-sectional sample of psychiatric adult inpatients,
included the following:
1. Presence of an anxiety diagnosis (any) will be statistically significantly
associated with suicidality (either suicide ideation or attempts), after
controlling for confounding by demographics.
2. Additionally controlling analytically for the presence of other psychiatric
diagnoses will not explain the expected association between anxiety diagnosis
and suicidality.
3. The presence of both an anxiety disorder and a depressive disorder will have a
synergistic effect on the risk of suicidality, as demonstrated by an increase in
risk of suicidality among patients with both an anxiety diagnosis and a
depression diagnosis compared to patients with neither diagnosis being greater
than the sum of the increases of risk for patients with an anxiety diagnosis
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alone and patients with a depression diagnosis alone, each compared to
patients without either diagnosis.
Additional research questions that were examined but not formally statistically tested
included the following,
4. Crude analysis will suggest that anxiety symptoms are statistically
significantly associated with suicidality (either suicide ideation or attempts).
5. Crude analysis will suggest that depressive symptoms are statistically
significantly associated with suicidality (either suicide ideation or attempts).
6. Crude analysis will suggest that the relative risk of suicidality for anxiety
symptoms (presence versus absence) will be greater than the relative risk of
suicidality for a diagnosis of an anxiety disorder (any – yes/no).
7. Crude analysis will suggest that the relative risk of suicidality for depressive
symptoms (presence versus absence) will be greater than the relative risk of
suicidality for a diagnosis of a unipolar affective disorder (any – yes/no).
These crude analyses will inform the design of a subsequent, longitudinal
study.
8. In an examination of two-way interactions, the presence of both anxiety
symptoms and depressive symptoms will have a synergistic effect on the risk
of suicidality, as demonstrated by an increase in risk of suicidality among
patients with both anxiety symptoms and depression symptoms compared to
patients with no symptoms being greater than the sum of the increases of risk
for patients with anxiety symptoms alone and patients with depression
symptoms alone, each compared to patients without any symptoms.
15

Research Methods
This study was completed in collaboration with, and advice from, Dr. Stephen
Woolley, Senior Scientist at the Burlingame Center for Psychiatric Research and Education
at the Institute of Living (IOL) in Hartford, CT, who also served as thesis advisor. The study
was a quantitative, cross-sectional study drawing analytic goals from previous studies at the
IOL. The study was completed under the previous Hartford Hospital protocol (HH #2118)
and examined data routinely collected at the IOL. This cross-sectional analysis examined the
association between anxiety and suicidality after controlling for diagnoses,
psychopharmacology treatment and demographics. The Institute of Living/Hartford
Hospital’s Institutional Review Board (IRB) (protocol HH #2118 as referenced above)
previously approved the research conducted for the purposes of this thesis in compliance
with hospital and Federal research regulations for the protection of human subjects.

Sampling and Recruitment
Study subjects were drawn from the target population of adult (defined as greater than
or equal to 18 years of age) psychiatric inpatients admitted for care during the 10-year period
from January 2000-March 2009 at the IOL. This time period was selected in order to ensure
adequate statistical power but to avoid possible changes in diagnostic practice that might
occur over a longer time period. Participants were recruited using the IOL’s on-going
database of all admitted inpatients. The cross-sectional study sample consisted of 20,823
adults for whom data were collected upon admission to the IOL by the hospital’s Outcome
Assessment Program (OAP). In addition to the cross-sectional analysis, a substudy of
patients who completed OAP follow-up post-discharge questionnaires during the final five
16

years of the ten-year period was examined to assess patients over time. The subsample
included all 948 adult patients who voluntarily completed OAP questionnaires at 1 month
follow-up and all 202 patients who voluntarily completed OAP questionnaires at 6 month
follow-up. At no point did the research restrict or impact receiving appropriate mental health
care as the IRB assured that the continuity and unfettered delivery of patient care and
confidentiality was maintained.

Data Collection
The IOL routinely administers these self-reported OAP questionnaires upon hospital
admission. Post-discharge, the IOL then mails OAP questionnaires to all previous inpatients
at 1 month and 6 month follow-up. In addition, data recorded in the hospital’s clinical
database included inpatient diagnoses, demographics (such as age, race, sex, and ethnicity),
and psychopharmacologic agents utilized in treatment. Symptom information recorded from
post-discharge returned OAP responses and entered into the OAP database included anxiety
and depression symptoms. The OAP questionnaires, developed by Dr. John Goethe at the
IOL, which include symptom questions (see Appendix B) adapted from the McLean Hospital
Basis-32 (Eisen, Grob, & Klein, 1989), is used in evaluating treatment
outcome/improvement.
The two primary independent variables included diagnoses of anxiety and of
depression. A diagnosis of anxiety consisted of PTSD, SAD, GAD, obsessive-compulsive
disorder (OCD), and/or PD. A diagnosis of depression consisted of having any of the
following disorders: major depressive disorder, mood disorder not otherwise specified,
dysthymic disorder, or depressive disorder not otherwise specified. Bipolar disorder and its
17

variants were excluded from the study because mixed and manic states, which can involve
symptoms relating to both depression and anxiety, would have rendered results
uninterpretable. Anxiety symptoms were defined as having fear, anxiety, or panic with a
response of “none” or “little” representing the absence of symptoms and “moderate,” “quite
a bit,” or “extreme” representing the presences of symptoms. Similarly, the presence versus
absence of depressive symptoms was rated on the same dichotomous scale.
During the study, factors targeted for control analytically included age, race, sex,
ethnicity, psychopharmalogical agents, other mental illness diagnoses, and personal difficulty
in the previous month with problems or areas of daily life (e.g., managing day-to-day,
relationship with family, self-confidence, disturbing thoughts). These covariates were
assessed for possible confounding of the analysis of risk of suicidality associated with
anxiety or depression diagnoses. We collapsed categories of responses about difficulties to
compare patients having “none,” “little,” or “moderate” difficulty with those having “quite a
bit” or “extreme” difficulty. In addition, we examined these variables dichotomized with
other cut-points.
The dependent variable for all analyses was suicidality coded dichotomously by
collapsing categories of responses to a question asking about difficulty in their every day
lives during the past month with “suicidal feelings or behavior (thinking about or attempting
suicide by any means).” Absence of suicidality was indicated if patients indicated that they
had “none” or “little” difficulty, and presence of suicidality if they had “moderate,” “quite a
bit,” or “extreme” difficulty.
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Data Analysis
The following analytical approach was based on approaches utilized in the
Burlingame Center (Woolley, Fredman, Goethe, Lincoln, & Heeren, 2008; Diefenbach,
Woolley, & Goethe, 2009) and executed under the direction of Dr. Woolley. Descriptive
statistics were utilized to examine the properties of the population with implications for
generalizability. Bivariate analyses were examined to further describe the study population,
to assess the crude hypothesized associations, and to investigate the crude associations
between potential confounders (identified in the literature or selected by the authors based on
theories of the progression of suicidality) that might affect the results of hypothesis testing.
Estimates of effects calculated in all analyses were odds ratios (ORs), and indications of the
precision of these estimates were expressed as 95% confidence intervals (CIs) calculated by
the approximate method. For these and stratified analyses, variables were dichotomous.
In addition, we examined the significance of pairwise associations of variables using
t-tests, one-way analysis of variance (ANOVA) or Pearson correlation coefficients to assess
associations involving continuous measures, and chi-square analysis for paired dichotomous
variables. Following bivariate analysis, we stratified the analysis of the associations between
primary exposures and outcomes by strata of covariates that appeared to be associated with
these exposures and outcomes. These analyses allowed us to estimate the adjusted ORs while
controlling for confounding by individual covariates. The ORs were estimated by calculating
the Mantel-Haenszel pooled estimator of the ORs (Rothman & Greenland, 1998). Stratified
analysis also allowed us to examine for modification of the effects of exposures on outcomes,
and to characterize the effect on risk of suicidality of dual exposures to anxiety or depression
and a covariate. In this way, we assessed interaction reflecting possible synergy or
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antagonism of primary exposures with additional patient characteristics. We judged evidence
of synergism or antagonism by applying the criteria that deviations of the combined effects
from additivity of the individual effects were

25% among the doubly exposed. Finally, we

constructed binary logistic regression models of the risk of suicidality by controlling for
demographics and other identified potential confounders, and selecting additional covariates
using a stepwise selection algorithm (p = 0.10 inclusion/removal criterion).
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CHAPTER IV
RESULTS
Univariate/Descriptive Analyses
From univariate analysis, it was determined that the population consisted of 10,767
females and 10,056 males for a total target population of 20,823 patients. The mean age was
43.0 years of age with patients ranging from age 18 to 102. Race was collapsed into a
dichotomous variable with 13,020 patients who identified as White and 7,803 who identified
as Black, Asian, Native American Indian, Hispanic, or Other, all of whom we categorized as
Non-White. There were 8,821 inpatients carrying depression diagnoses and 2,967 patients
carrying anxiety diagnoses. Expressing moderate to extreme suicidality, there were 12,126
individuals. A complete list of variables that we assessed is included below in Table 2A.

Table 2A. Univariate Analysis (n = 20,823)
At admission
Potential Confounders
Demographics
gender
race/ethnicity

N
10,767
10,056

female
male
White

%
51.7
48.3
62.5

13,020

Black, Asian, Native American Indian,
Hispanic, Other

Mean
43.0

age (years)
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37.5

7,803
SD
17.5

Range
18-102

Key Variables
Anxiety (Includes PTSD, SAD, GAD, OCD,
and PD)

N
2,967

%
14.2

PTSD
anxiety disorder not PTSD

1,866
1,218
8,821

9.0
5.8
42.4

major depressive disorder
dysthymic disorder
depressive disorder NOS
mood disorder NOS
greater than (but not
including) little

7,252
163
1,328
146
12,126

34.8
0.8
6.4
0.7
58.2

N
3,137
10,134
2,565
3,103
827
340
284
351
5
202
34
28
97
14
32
1,669
83
6,862
2,284
Mean
2.0
N
14,901
9,909
672
24
8,622
14,497
8,060

%
15.1
48.7
12.3
14.9
4.0
1.6
1.4
1.7
0.0
1.0
0.2
0.1
0.5
0.1
0.2
8.0
0.4
33.0
11.0
Range
0 - 10
%
71.6
47.6
3.2
0.1
41.4
72.0
38.7

Depression
(Includes MDD, mood disorder NOS,
dysthymic disorder, or depressive disorder
NOS)

Suicidality

Potential Confounders
Diagnoses
bipolar (BP) disorder
substance use disorder
Schizophrenia
schizoaffective disorder
other psychotic disorder
eating disorder
adjustment disorder
impulse control disorder
oppositional defiant disorder
attention deficit disorder
Paraphilia
conduct disorder NOS
Delirium
personality change d/t medical condition
pervasive developmental disorder
Dementia
cognitive disorder NOS
personality disorder (any)
borderline personality disorder
Number of psychiatric diagnoses
Medications

antidepressant anytime
SSRI anytime
TCA (tricyclics) anytime
MAOI anytime
other antidepressant anytime
antipsychotic anytime
anticonvulsant anytime
(mood stabilizers)
lithium anytime
stimulant anytime
benzodiazepine anytime
polypharm anytime

1,643
140
7,962
2,171
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SD
1.4

7.9
0.7
38.2
10.4

Potential Confounders
ECT
Symptoms
Difficulty managing day-to-day life (greater than
moderate)
Difficulty managing day-to-day life (greater than little)
Length of stay
(days)

N

%

975
18,232

4.7
87.6

20,790

99.8
SD

Mean
7.0

Range

10.0

1-224

Univariate analyses for the 1 month and 6 month data subsets were then examined (Tables
2B and 2C). Although anxiety and depression symptom information was not available at
admission, symptom information was collected at the 1 month and 6 month follow-ups.
Table 2B. Univariate Analysis (n = 948)
At one month follow-up
Key variables

Variables

Symptoms

anxiety symptoms (fear, anxiety or panic)
depressive symptoms (depression, hopelessness)
suicidal feelings or behaviors (moderate to extreme)
difficulty managing day to day

n

%

432
496
215
326

44.8
51.5
22.7
33.7

n

%

81
99
45
55

39.3
47.8
22.3
26.6

Table 2C. Univariate Analysis (n = 202)
At six month follow-up
Key variables

Variables

Symptoms

anxiety symptoms (fear, anxiety or panic)
depressive symptoms (depression, hopelessness)
suicidal feelings or behaviors (moderate to extreme)
difficulty managing day to day

Bivariate Crude Analyses
By utilizing bivariate analysis, crude odds ratios (ORs) were determined in order to
evaluate any possible associations between variables that suggest these variables might
confound the anxiety diagnosis-suicidality or the depression diagnosis-suicidality
association. A diagnosis of anxiety or depression was associated with an increased risk of
having both anxiety and depression (OR = 3.13; CI = 2.88, 3.39). Furthermore, when looking
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at the crude analysis, depression was associated with an increased risk for suicidality (OR =
3.53; CI = 3.33, 3.75) and anxiety was associated with an increased risk for suicidality (OR =
2.80; CI = 2.56, 3.07). Impulse control disorder, oppositional defiant disorder, and paraphelia
were not associated with anxiety, depression or suicidality. Numerous diagnoses were
associated with risk for suicidality as shown below in Table 3A.
Male gender was associated with a lower risk of having anxiety and depression (OR =
0.39; CI = 0.36, 0.43 and OR = 0.56; CI = 0.53, 0.59 respectively), and was associated with a
slightly lower risk for suicidality (OR = 0.91; CI = 0.86, 0.97). Being Non-White was
associated with a decrease in the odds of having anxiety and depression but an increase in the
risk for suicidality. Also, antidepressants, including selective serotonin reuptake inhibitors
(SSRIs), stimulants, and polypharmacology (in this case, the use of more than one
psychopharmacological agent) were associated with an increase in risk for suicidality.
Lithium and antipsychotics were the only medications associated with a decreased risk for
suicidality from the crude analysis. Difficulty managing day-to-day life, both greater than a
little and greater than moderate, was associated with a significant elevation in the odds ratio
for suicidality (greater than a little OR = 3.16; CI =2.89, 3.44; greater than moderate OR =
9.04; CI = 7.33, 11.15).
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Table 3A. Bivariate Analysis At Admission
(n = 20,823)
OR = odds ratio

Suggests decreased risk of suicdality

CI = confidence interval, 95%

Suggests increased risk of suicidality
Anxiety Diagnoses
(n1 = 2,967)

Demographics

Variable
Gender: male
Race: Other
(Black, Asian, Native
American Indian,
Hispanic, Other)

% of n1
29.46
32.82

CI
0.36, 0.43
0.73, 0.86

Yes
No
40.19
46.01
t = 16.91, p < 0.05

% of n3
47.34
40.63

OR
0.91
1.39

CI
0.86, .97
1.31, 1.47

Key
Variables
Symptoms

XXXX

XXXX

XXXX

22.23

66.09

3.13

2.88, 3.39

XXXX

XXX

XXXX

18.94
54.55

90.76

1.44

1.27, 1.65

87.56

1.00

0.92, 1.09

92.77

3.16

2.89, 3.44

97.60

1.58

1.23, 2.02

96.12

0.90

0.77, 1.04

99.04

9.04

7.33, 11.15
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Yes
No
44.45
45.71
t = 5.17, p < 0.05
3.13
2.88 , 3.39

Suicidality
(n3 = 12,126)
(greater than little)

Yes
No
40.67
51.46
t= 46.14, p < 0.05
2.80
2.56, 3.07
3.53
3.33, 3.75

Age
Anxiety
Depression
(Includes MDD, mood
disorder NOS, dysthymic
disorder, or depressive
disorder NOS)
Difficulty managing dayto-day life (greater than
moderate)
Difficulty managing dayto-day life (greater than
little)

OR
0.39
0.79

Depression
(n2 = 8,821)
(Includes MDD, mood disorder
NOS, dysthymic disorder, or
depressive disorder NOS)
% of n2
OR
CI
40.02
0.56
0.53, 0.59
36.40
0.92
0.87, 0.98

Variable
Dementia
Schizophrenia
Schizoaffective
Major depressive disorder
Other psychotic disorder
PTSD
Anxiety disorder not PTSD
Diagnoses
Medications
ECT

Substance use disorder
Eating disorder
Adjustment disorder
Attention deficit disorder
Bipolar disorder
Conduct disorder
Delirium
Pervasive developmental
disorder
Cognitive disorder NOS
Personality disorder
Borderline Personality
disorder
Antipsychotic anytime
Antidepressant anytime
SSRI anytime
Anticonvulsant anytime
Lithium
Benzodiazepine anytime
Polypharm anytime
Stimulant anytime
ECT

% of n1
1.35
2.53
9.44
60.47
1.42
62.89
41.05

Anxiety Diagnoses
OR
CI
0.14
0.10, 0.19
0.16
0.13, 0.20
0.56
0.49, 0.63
3.46
3.19, 3.75
0.31
0.23, 0.43
N/A
N/A
N/A
N/A

% of n2
3.78
0.49
1.07
82.21
1.45
13.50
9.64

Depression Diagnoses
OR
CI
0.31
0.28, 0.35
0.02
0.01, 0.03
0.03
0.03, 0.04
N/A
N/A
0.24
0.20, 0.29
2.62
2.37, 2.89
3.37
2.97, 3.82

% of n3
2.44
6.70
14.12
45.56
2.64
12.63
7.03

OR
0.13
0.28
0.86
3.37
0.44
3.61
1.73

Suicidality
CI
0.12, 0.15
0.26, 0.31
0.80, 0.93
3.17, 3.60
0.38, 0.51
3.19, 4.07
1.52, 1.96

48.50
3.71
0.91
1.79
15.00
0.00
0.17
0.27

0.99
2.95
0.63
2.16
0.99
N/A
0.33
2.01

0.92, 1.07
2.34, 3.72
0.42, 0.94
1.58, 2.96
0.89, 1.11
N/A
0.13, 0.80
0.90, 4.48

50.11
2.68
1.00
1.13
0.67
0.02
0.40
0.11

1.11
3.15
0.61
1.34
0.02
0.10
0.77
0.62

1.05, 1.17
2.49, 3.97
0.47, 0.78
1.01, 1.77
0.02, 0.03
0.03, 0.44
0.51, 1.16
0.29, 1.31

56.39
2.19
1.68
1.12
15.11
0.03
0.22
0.08

2.12
2.57
1.84
1.48
1.01
0.12
0.28
0.33

2.00, 2.24
1.99, 3.32
1.42, 2.39
1.10, 1.99
0.93, 1.09
0.04, 0.34
0.18, 0.43
0.15, 0.69

0.27
53.05
27.00

0.64
2.69
4.08

0.31, 1.33
2.48, 2.91
3.71, 4.50

0.57
41.06
14.37

2.07
1.88
1.82

1.33, 3.21
1.78, 2.00
1.66, 1.98

0.35
43.54
15.99

0.77
3.47
4.61

0.50, 1.19
3.25, 3.70
4.10, 5.19

69.87
90.63
62.89
41.15
6.07
50.29
14.80
0.71
5.29

0.89
4.47
2.07
1.13
0.72
1.78
1.62
1.06
1.17

0.81, 0.96
3.94, 5.08
1.91, 2.24
1.04, 1.22
0.62, 0.85
1.65, 1.93
1.44, 1.81
0.67, 1.69
0.98, 1.39

56.15
94.38
67.03
25.46
2.22
39.69
7.38
1.10
7.63

0.25
13.85
4.07
0.36
0.17
1.11
0.55
3.09
3.20

0.23, 0.27
12.56, 15.27
3.84, 4.32
0.34, 0.39
0.14, 0.19
1.05, 1.18
0.50, 0.61
2.16, 4.43
2.79, 3.68

68.12
83.37
56.92
38.28
7.22
37.29
12.10
0.83
4.64

0.62
4.09
2.50
0.96
0.81
0.91
1.56
1.87
0.98

0.58, 0.66
3.84, 4.36
2.36, 2.65
0.91, 1.01
0.73, 0.89
0.86, 0.96
1.42, 1.72
1.29, 2.70
0.86, 1.11
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We then turned to bivariate analyses comparing admission data with 1 month and 6
month data. Whereas the anxiety diagnoses examined in crude bivariate analysis at follow-up
were associated with a decrease in suicidality, anxiety symptoms were associated with an
increased risk of suicidality at 1 month post-discharge (OR = 8.30, CI = 5.70, 12.09) and at 6
months post-discharge (OR = 18.69, CI = 7.36, 45.45). Additional crude analyses for
depression symptoms and difficulty managing from day-to-day at 1 month and 6 month
follow-up are described in Table 3C and 3D.

Variable
Anxiety
Diagnoses
Depressive
Diagnoses
Difficulty
Managing
Day to Day

Variable
Anxiety
Symptoms
Depressive
Symptoms
Difficulty
Managing
Day to Day
Anxiety
Diagnoses
Depressive
Diagnoses
(any except
bipolar)

Table 3B. Subsample: Bivariate at Admission For Comparison (n = 2,040)
Anxiety Diagnoses (n1=276)
Depressive Diagnoses
Suicidality (n3=942)
(any except bipolar) (n2=869)
(moderate to extreme)
% of
OR
CI
% of
OR
CI
% of
OR
CI
n1
n2
n3
XX
XX
XXXX
21.63
3.40
2.59, 4.45
13.69
.93
0.68, 1.28
68.12

3.40

2.59, 4.45

XX

XX

XXXX

44.06

1.10

0.88, 1.37

68.48

0.97

0.47, 2.00

67.78

1.17

0.70, 1.96

99.04

13.08

6.39, 26.77

Table 3C. Bivariate at 1 Month Follow-up (n = 948)
Anxiety Symptoms (n1=432)
Depressive Symptoms
Suicidality (n3=215)
(fear, anxiety or panic)
(n2=496)
Suicidal feelings or behaviors
(depression, hopelessness)
(moderate to extreme)
% of
OR
CI
% of
OR
CI
% of
OR
CI
n1
n2
n3
XX
XX
XXXX
70.56 11.78
8.64, 16.05
80.93
8.30
5.70, 12.09
81.02

11.78

8.64, 16.05

XX

XX

XXXX

92.56

26.29

14.41,47.96

56.71

7.60

5.59, 10.33

53.63

8.22

5.93, 11.41

66.05

6.00

4.32, 8.34

11.11

0.87

0.59, 1.29

12.10

1.06

0.71, 1.56

10.70

0.89

0.54, 1.43

45.60

1.09

0.85, 1.41

46.37

1.21

0.94, 1.56

46.05

1.10

0.81, 1.50
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Variable
Anxiety
Symptoms
Depressive
Symptoms
Difficulty
Managing
Day to Day
Anxiety
Diagnoses
Depressive
Diagnoses
(any except
bipolar)

Table 3D. Bivariate at 6 Month Follow-up (n=202)
Anxiety Symptoms
Depressive Symptoms
Suicidality
(n1=81)
(n2=99)
(n3=45)
(fear, anxiety or panic)
(depression, hopelessness)
Suicidal feelings or behaviors
(moderate to extreme)
% of
OR
CI
% of
OR
CI
% of
OR
CI
n1
n2
n3
XX
XX
XXXX
73.74 36.50 15.58, 85.52 86.67 18.69
7.36, 47.45
90.12

36.50

15.58, 85.52

XX

XX

XXXX

97.78

88.00

11.79, 656.69

55.56

16.57

7.38, 37.23

47.47

13.30

5.61, 31.50

64.44

9.06

4.32, 19.02

14.81

1.11

0.50, 2.46

18.18

1.96

0.88, 4.39

11.11

0.77

0.27, 2.16

51.85

1.29

0.73, 2.25

51.52

1.33

0.77, 2.30

53.33

1.35

0.69, 2.62

Stratified analysis was then used to assess for evidence that demographics, diagnoses,
or pharmacological agents confounded the anxiety diagnosis - suicidality association. These
analyses suggest that antidepressant use and having greater than little difficulty (includes
“moderate,” “quite a bit,” or “extreme”) managing day-do-day variables confound but do not
modify the anxiety diagnosis – suicidality association. We found no evidence that the
variables examined confounded the depression diagnosis – suicidality association.
Two-way interactions were then used to assess for synergism and antagonism. As
described in the Methods section, if we found that excess risk in the doubly exposed category
was greater than the sum of the two singly exposed categories by a margin of ± 25%,
synergism was suspected.
Analysis of anxiety and depression diagnoses provided no evidence of synergism in
the risk of suicidality. Evidence of synergism was found between an anxiety diagnosis and,
gender
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difficulty managing day-to-day greater than a little
difficulty managing day-to-day greater than moderate
antipsychotics
antidepressants (not the subcategory of SSRI’s)
polypharmacological agents
stimulants
borderline personality disorder.
A depression diagnosis and the following variables met our criterion for synergism,
difficulty managing from day-to-day greater than a little
difficulty managing from day-to-day greater than moderate
substance use disorder
antidepressants (slight)
lithium
If the doubly exposed category was less than the sum of the two singly exposed by a
margin of ± 25%, antagonism was suspected. The only variable that appeared to act
antagonistically on the effect of anxiety (diagnoses) on suicidality was eating disorder.
Variables that appeared to act antagonisitcally on the effect of depression (diagnoses) on
suicidality included race, benzodiazepines, and ECT.
Through analysis of two-way interactions at 1 month, findings suggested that anxiety
symptoms and depressive symptoms acted synergistically to increase the risk of suicidality
(see Table 4 below). Evaluating two-way interactions at 6 month was not possible due to
devisors of 0 in the denominators.
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Table 4. Example of assessing interaction on an additive scale for two dichotomous
exposures and a dichotomous outcome

Cases
Non-Cases
Total

ONE MONTH FOLLOW-UP
Exposure 1
Exposure 2 Non-exposure 2
163
35
Cases
180
101
Non-cases
136
343

Non-exposure 1
Exposure 2 Non-exposure 2
9
3
70
374
79
377

Exposure 1= Difficulty with depression, hopelessness at 1 month follow-up
Exposure 2 = Difficulty with fear, anxiety, panic at 1 month follow-up
Cases = Difficulty with suicidal feelings or behaviors at 1 month follow-up
Additivity criteria

R ( AB )
R ( AB )
112.89

=> If the equality holds, no interaction

R ( AB )
R ( AB )

R ( AB )
R ( AB )

1

≠ 58.23 => Interaction or synergism as equality does not hold by a margin > 25%

Binary Logistic Regression
The next analysis we performed was binary logistic regression (results shown in
Table 5). The model fit was assessed for the regression model of risk of suicidality at
admission, and the Nagelkerke R Square was 0.35. Variables that were forced into the
equation included anxiety, depression, age, race, and gender. The remainder of the variables
were entered as covariates and selected for retention in the model by forward stepwise
conditional method. Anxiety diagnoses was associated with an increased risk for suicidality.
After controlling for demographics, diagnoses and medications, the OR for anxiety diagnosis
was 1.38 (CI = 1.24, 1.35) indicating that an anxiety diagnosis was statistically significantly
associated with a 38% increased risk of suicidality. Many mental illnesses including axis II
diagnoses were associated with an increase in suicidality including schizoaffective,
borderline personality disorder, substance abuse disorder, adjustment disorder, and bipolar
disorder. Certain diagnoses such as schizophrenia decreased the risk for suicidality (OR =
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0.60 , CI = 0.53, 0.68). Some medications decreased the risk for suicidality while
antidepressants, for example, increased the odds ratio for sucidality. Again, difficulty
managing day-to-day significantly increased suicidal risk more than 7 fold (OR = 7.86, 6.24,
9.90). The following variables were eliminated during stepwise regression: eating disorder,
impulse control disorder, oppositional defiant disorder, paraphilia, conduct disorder,
delirium, personality change due to a medical condition, antipsychotic (any), anticonvulsant
(any), stimulant (any), and ECT.
In subanalyses, we then analyzed suicidality at 1 and 6 month follow-ups, forcing the
variables that were maintained in the above model into a new binary logistic regression
analysis. The results were not statistically significant as demonstrated in Table 5. In these
analyses, for some variables scant data resulted in variables included in the cross-sectional
analysis being dropped.
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Anxiety
Depression

Table 5. Regression Analyses: Variables Remaining In the Equation, OR and 95% CI
At admission
At one month follow-up
(n = 20,823; missing 55across
n = 530
various data points)
OR
CI
OR
CI
1.38
1.24, 1.53
0.89
0.46, 1.74
2.64
2.38, 2.94
0.88
0.43, 1.76

At six month follow-up
n = 115
OR
0.42
0.98

CI
0.09, 1.88
0.22, 4.27

Gender (Males)

1.25

1.17, 1.35

0.86

0.54, 1.38

0.46

0.15, 1.37

Race (Non-White)

1.35

1.26, 1.46

1.02

0.64, 1.63

0.92

0.32, 2.66

Age

0.97

0.97, 0.98

1.01

0.99, 1.03

1.02

0.98, 1.06

Dementia

0.49

0.42, 0.57

1.01

0.38, 2.67

0.17

0.01, 3.52

Schizophrenia

0.60

0.53, 0.68

0.71

0.30, 1.67

0.22

0.02, 2.19

Schizoaffective

1.24

1.10, 1.40

0.99

0.44, 2.27

0.46

0.06, 3.36

Other psychotic disorder

0.67

0.56, 0.80

0.75

0.19, 2.93

0.33

0.02, 4.99

Substance use disorder

1.42

1.32, 1.53

1.21

0.73, 2.00

0.73

0.23, 2.30

Adjustment disorder

1.85

1.38, 2.48

1.40

0.26, 7.62

0.62

0.05, 8.06

Attention deficit disorder

0.67

0.48, 0.92

4.05

0.51, 32.01

N/A

N/A

Bipolar disorder

1.53

1.35, 1.73

0.73

0.32, 1.69

0.42

0.07, 2.62

Pervasive developmental disorder

0.18

0.08, 0.39

0.00

N/A

N/A

N/A

Borderline Personality disorder

2.78

2.43, 3.18

1.33

0.65, 2.71

2.37

0.49,11.62

Antidepressants (any)

2.97

2.75, 3.22

1.35

0.80, 2.29

0.96

0.23, 3.98

Lithium (any)

0.90

0.79, 1.01

1.02

0.43, 2.42

0.60

0.31, 2.42

Benzodiazepine (any)

0.85

0.79, 0.91

0.71

0.45, 1.10

0.87

0.31, 2.42

Difficulty managing day-to-day greater than a little

7.86

6.24, 9.90

0.87

0.31, 2.46

0.00

N/A
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CHAPTER V
DISCUSSION
Our study found that, in a sample of adult psychiatric hospitalized inpatients, anxiety
and depression diagnoses were associated with approximately 40% and 160% increased risk
of suicidality, after controlling for demographic and clinical confounders. Furthermore, our
analysis provided evidence that the effects on risk of suicidality of these two diagnostic
groups were independent, neither synergistic nor antagonistic. However, our analysis
provided evidence that many other personal and clinical factors did interact with either
anxiety or depression diagnosis to modify these diagnoses’ association with suicidality.
We have already established that the role of anxiety in suicidality is complicated. In
the passage below, noted author William Styron provides a glimpse at the damaging effects
of anxiety:
But it is my conviction now that alcohol played a perverse trick on me when
we said farewell to each other: although, as everyone should know, it is a
major depressant, it had never truly depressed me during my drinking career,
acting instead as a shield against anxiety. Suddenly vanished, the great ally
which for so long had kept my demons at bay was no longer there to prevent
those demons from beginning to swarm through the subconscious, and I was
emotionally naked, vulnerable as I had never been before. (Styron, 1990, p.
43).
In William Styron’s memoir, Darkness Visible, he described how anxiety played a significant
role in the progression and development of his depression, resulting in suicidal ideation. In
fact, Styron believed alcoholism is what dampened his anxiety and staved off his depression.
Despite such vivid accounts detailing how anxiety can prompt suicidality, there is still much
disagreement about the anxiety – suicidality association. For example, one study not only
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suggested that comorbid panic disorder and depression in psychiatric inpatients (each patient
had at least one major depressive episode with or without a suicide attempt history) did not
increase lifetime suicide attempts but instead that higher levels of anxiety and agitation
offered protection against suicidality in the target population of 272 patients (Placidi et al.,
2000). However, as already described in the results, our study within the inpatient adult
population demonstrated that anxiety was statistically significantly associated with
suicidality after controlling for confounders including other psychiatric diagnoses (such as
depression). Even though our research did not delineate ideation from attempts or completed
suicide, our results suggest that clinicians need to be aware of the significant role that anxiety
may play in the development of suicidal behaviors. This conclusion is reinforced by the
WHO’s cross-national analysis, examining the association of mental disorders and suicidal
behavior, which suggested that clinicians should be mindful that anxiety may be an important
risk factor influencing whether a patient transitions from suicidal thoughts to attempts or
even to completed suicide (Nock et al., 2009). Although we did not find synergism or
antagonism when an anxiety diagnosis was coupled with a unipolar depression diagnosis,
both diagnoses were statistically significantly associated with increased suicidality, providing
evidence that an anxiety disorder should be considered a risk factor, independent of
depression, for suicidal behaviors.
Further suggesting an association between anxiety and suicidality, benzodiazepines
which are used in the treatment of anxiety disorders, were associated with a reduced risk of
suicidality in both the bivariate and regression analyses. Therefore, the administration of
benzodiazepines in a patient who presents with an anxiety diagnosis could potentially be
therapeutic in preventing suicidal behaviors. Antipsychotics, anticonvulsants, and stimulants
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were not retained for inclusion in the regression model, indicating that these
psychopharmacological agents were not statistically significantly associated with suicidality
after controlling for other factors’ effects. However, antidepressants were associated with
increased risk of suicidality, suggesting that care should be taken when administering this
medication and that patients should be carefully monitored for signs of developing
suicidality. In fact, one commonly listed side effect of certain antidepressants is anxiety
(Mayo Foundation for Education and Research, 2008) which perhaps may account for the
increased suicidal risk found in our sample, despite these medications’ presumed alleviation
of depressive symptoms. Joiner (2010) described that antidepressants might be “activating”
and that too much activation might result in anxiety, agitation, and restlessness, which he
notes as indicators for high risk of suicidality. In this author’s (MT) personal communication
with T. Joiner, he remarked:
I often say in trainings “I've never heard anyone about to die or almost die by
suicide described as sluggish... agitated, on edge, can't sleep, hyped up,
nervous energy, yes - but never sluggish.” This state is key to understanding
suicidal behavior, and it is underappreciated. (March 14, 2010)
Fawcett (Jancin, 2003) made similar references regarding suicidality at the Annual
Conference of the American Association of Suicidology (Santa Fe, 2003). Fawcett even
indicated that it was his professional goal to have the severity of a patient’s anxiety assessed
as part of routine clinical suicidal assessments. In a study, Busch and Fawcett (2003)
examined the suicide risk of inpatients. Chart reviews were completed on 76 patients
between the ages of 15-76 who committed suicide while they were in inpatient treatment.
Items from the Schedule for Affective Disorders and Schizophrenia (SADS) and traditional
risk factors (including previous suicide attempt and suicidal ideation) had been evaluated
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during the week before the patient committed suicide. Surprisingly, 78% denied any suicidal
ideation during their “last communication” and the researchers concluded that the standard
risk predictors were in fact “not predictive” for acute risk (Busch & Fawcett, 2003).
However, in the last week of their lives, 79% of inpatients had met the SADS criteria for
severe anxiety or agitation. This raises the point that suicide assessments that only focus on
questions regarding ideation, intent, plan and lethality of method may have limited utility as
predictors of completed suicides. Furthermore, due to the tremendous stigma of suicide
(Joiner, 2005), people may feel reluctant to admit suicidality; however, one could surmise
that patients would more readily admit to severe anxiety (as the above study suggests) giving
credence to Fawcett’s professional goal.
Obviously not everyone with symptoms of anxiousness meets criteria for a DSM-IVTR (2000) anxiety diagnosis. Logically, because our research indicated that an anxiety
diagnosis was associated with increased suicidality (after controlling for numerous
covariates), the next step was to discern if the presence of the symptoms of anxiety (without
an anxiety diagnosis or by controlling for various anxiety diagnoses) was predictive of
suicidality. In our preliminary analysis of the presence versus absence of anxiety symptoms
in adult inpatients (who did not necessarily have an anxiety diagnosis) at 1 month post
discharge, the presence of anxiety symptoms was associated with an 8-fold increased suicidal
risk. One possible explanation is that anxiety may in fact be one of the underlying
commonalities across mental illnesses that accounts for the risk of suicidality. One could
argue that the presence of mental illness, and perhaps any type of illness that is not
completely curable, is indeed anxiety provoking. Although our findings were not conclusive
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of this point, these preliminary data suggest that an analysis of symptoms or symptom
clusters may better predict suicidal risk than a DSM-IV diagnosis.
For example, in this study difficulty managing from day-to-day (greater than a little),
an indicator of stress that might be expected to increase anxiety, was strongly associated with
a 7-fold increased risk for suicidality. However, The Columbia Suicide Severity Rating Scale,
(Posner et al., 2008) and The Reasons for Living Inventory (Linehan, Goodstein, Nielsen, &
Chiles, 1983) do not directly assess client anxiety or difficulty managing from day-to-day.
Nonetheless, our data suggest that instruments such as these might be complemented by
asking about anxiety and difficulty managing from day-to-day and that asking these clinical
questions may be important because suicidal patients may be reluctant to admit they are at
risk (Busch & Fawcett, 2003).
In addition, when analyzing two-way interactions in a preliminary analysis, we found
that the risks associated with anxiety symptoms and depression symptoms were synergistic;
i.e., the risk in patients having both symptoms exceeded the risk expected from the additive
effects of suicide risk due to depression symptoms alone plus suicide risk due to anxiety
symptoms alone. Further research is warranted to examine the effects of symptom clusters on
suicidal risk. Intimating that there is not just one factor responsible for suicidality, in Joiner’s
personal correspondence (personal communication, March 14, 2010) he indicated that
depression, anxiety and numerous other factors exert influence on suicidality. However,
Joiner stated that he believed that these biological, social, or environmental risk factors exert
influence through a common pathway that ties together dozens of risk factors. The theoretical
model that he proposes, which outlines his idea of the common pathway, is that suicidality
occurs when there is a combination of learned fearlessness (“a type of habituation to suicidal
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behaviors which impedes the fear and pain associated with self-harm”), and two
simultaneously occurring long-term mind-states (Joiner, 2005, p. 59). The first mind state is
perceived burdensomeness where a person perceives that he (she) is a burden and his (her)
death is worth more than his (her) life to others. The second mind-which is termed failed
belongingness is the person’s perception that he (she) is completely alienated from others
(see Figure 1 below).
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FIGURE 1. ADAPTED FROM JOINER: WHY PEOPLE DIE BY SUICIDE

SUICIDE

LEARNED FEARLESSNESS Acquisition of the ability to enact lethal self-injury that
causes one to become suicidal acquired through time and repetition.
SUICIDAL
BEHAVIORS

Adapted with permission from T. Joiner,
personal communication, May 14, 2010
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The relevance of Joiner’s theory to the current study’s findings are that multiple
factors might act in concert to overcome the will to live, indicating that more research about
the effects of symptoms and symptom clusters is needed to assess the independent and
combined roles they may play in the risk of suicidality, and the need to further qualify the
nature of the anxiety. Additional analysis of anxiety and the risk of suicidality may indicate
that the symptom of anxiety is truly part of the “common pathway” and not an ancillary
contributing factor. In this case, anxiety associated with suicidality might be examined for
evidence that it has specific qualities that produce so much discomfort that the patient
inherently can no longer cope with the pain and needs an immediate change. Fawcett and
Harris (2001) described it as a “ruminative form of anxiety,” eloquently stating “the constant
repetition of this increasingly fearful idea becomes inescapable torture for the patient, true
psychic pane, from which the idea that the only escape is death seems a logical conclusion”
(p. 480). In an examination of Joiner’s theoretical model, one might ask what came first, the
habituation/learned fearlessness to risk bodily harm or the ruminative anxiety about
continuing to cope in the world? This author (MT) suggests that a person’s inability to
tolerate this frenetic form of anxiety may be the common pathway to suicidality and that an
acquired ability to enact lethal self-injury through time and repetition, although certainly a
risk factor, is not necessarily part of “the common pathway.”
If learned fearlessness was in fact the common pathway for completed suicide, one
would potentially expect that with each additional trauma [as Joiner (2005) indicates that
repetitive exposure to trauma could be a contributing factor to learning fearlessness] there
would be an additive or supra-additive effect of each trauma increasing the risk for suicidal
ideation and attempt. However, in a study recently conducted with data from the WHO
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World Mental Health Surveys (Stein et al., 2010), findings suggested that although there was
a dose-effect of an increase in suicidal ideation and attempt as the number of trauma
exposures increases, there is a subadditive effect in the strength of the association with
suicidal ideation and attempt. In other words, the magnitude of the effect of each additional
trauma on suicidality, decreases with each exposure (Stein et al., 2010). Again, future
research on anxiety symptoms in relationship to suicidality is warranted.
Limitations
Measurement errors may have occurred because data were obtained from clinical
records and via patient self-reports, and because of retrospective reports and any limitations
in scales. For example, when measuring suicidality (an ordinal variable) we cannot assume
that the magnitude of the change in morbidity between “no” and “little” suicidality is equal to
the magnitude between “quite a bit” and “extreme.” This limitation was addressed by
dichotomizing suicidality while assuming the ordinal nature of the original Likert scale. For
the substudy analysis, there is the possibility that selection bias was introduced if only certain
categories of patients were willing to respond to the questionnaires mailed at 1 and 6 month
follow-up.
An additional limitation involves the lack of symptom (in contrast to diagnoses)
information recorded at admission and discharge into the hospital database during the
designated study period. As a result, we were unable to draw comparisons between
admission and post-discharge anxiety symptoms, and thus we could not establish that
independent variables preceded suicidality. Also, because the population consisted only of
psychiatric inpatients, there is a question about generalizability to a broader clinical
population or to the general population at-large.
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Although there are limitations in this study, the potential benefit to clinical practice
from a large study including examination of combinations of potential risk factors not
thoroughly examined in previous research has merit. This study provides additional
understanding about the associations of anxiety and depression with suicidality which has
obvious important implications for patient safety.
Conclusions
In conclusion, we found that anxiety diagnoses were associated with increased
suicidal risk when controlling for confounding in an inpatient adult population. As
anticipated, depression diagnosis was also associated with suicidality, but this diagnosis did
not explain the statistically significant association between anxiety diagnosis and suicidality.
We did not find a synergistic effect on suicidality when comorbid anxiety and depression
were present. Preliminary analyses suggest that anxiety symptom information may be a better
predictor of suicidality than the presence of a DSM-IV diagnosis. Additional research is
warranted to examine the nature of anxiety symptoms that precede suicidal behaviors and to
examine if symptom clusters work synergistically to increase suicidal risk as well as what
symptom clusters present the greatest suicidal risk.

42

References
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental
disorders (4th ed., text revision). Washington, DC: Author.
Beautrais, A., Joyce, P., Mulder, R., Fergusson, D., Deavoll, B., & Nightingale, S. (1996).
Prevalence and comorbidity of mental disorders in persons making serious suicide
attempts: A case-control study. American Journal of Psychiatry, 153, 1009-1004.
Bernal, M., Haro, J. M., Bernert, S., Brugha, T., de Graaf, R., Bruffaerts, R., et al. (2007).
Risk factors for suicidality in Europe: Results from the ESEMED study. Journal of
Affective Disorders, 101, 27-34.
Bongiovi-Garcia, M., Merville, J., Almeida, M., Burke, A., Ellis, S., Stanley, B., et al.
(2009). Comparison of clinical and research assessments of diagnosis, suicide attempt
history and suicidal ideation in major depression. Journal of Affective Disorders, 115,
183-188.
Busch, K. A., & Fawcett, J. (January, 2003). Clinical correlates of inpatient suicide. Journal
of Clinical Psychiatry, 64(1), 14-19.
Cougle, J., Keough, M., Riccardi, C., & Sachs-Ericcson, N. (2009). Anxiety disorders and
suicidality in the National Comorbidity Survey-Replication. Journal of Psychiatric
Research, 43, 825-828.
Diaconu, G., & Turecki, G. (2007). Panic disorder and suicidality: Is combidity with
depression the key? Journal of Affective Disorders, 104, 203-209.
Diefenbach, G., Woolley, S. B., & Goethe, J. W. (2009). The association between selfreported anxiety symptoms and suicidality. Journal of Nervous and Mental Disease,
197(3), 92-97.
43

Eisen, S. V., Grob, M. C., & Klein, A. A. (1989) Basis 32: A Self-Report Measure for
Evaluating Patient Progress. Belmont, MA: McLean Hospital.
Fawcett, J. (April 2009). Report of the DSM-V Mood Disorders Work Group. Retrieved June
13, 2009 from
http://www.psychiatry.org/MainMenu/Research/DSMIV/DSMV/DSMRevisionActivi
ties/DSM-V-Work-Group-Reports/Mood-Disorders-Work-Group-Report.aspx
Fawcett, J., & Harris, S. (2001). Suicide in treatment-refractory depression. In J. Amsterdam,
M. Hornig, & A. Nierenberg (Eds.), Treatment resistant mood disorders, New York:
Cambridge University Press, 479-490.
Goldsmith, S. K., Pellmar, T. C., Kleinman, A. M., & Bunney, W. E., Eds. (2002) Reducing
suicide: a national imperative. Washington (D.C.): The National Academies Press.
Retrieved on October 17, 2009 from
http://www.nap.edu/openbook.php?record_id=10398&page=3
Gonda, X., Fountoulakis, K. N., Kaprinis, G., & Rihmer, Z. (2007). Prediction and
prevention of suicide in patients with unipolar depression and anxiety. Annals of
General Psychiatry 6doi:10.1186/1744-859X-6-23.
Heron, M. P., Hoyert, D. L., Murphy, S. L., Xu, J. Q., Kochanek, K. D., & Tejada-Vera, B.
(2009). Deaths: Final data for 2006. National Vital Statistics Reports 57,(14).
Hyattsville, MD: National Center for Health Statistics.
Jancin, B. (2003, July). Factors for acute suicide risk are not widely recognized. Clinical
Psychiatry News, 31(7), 32.
Joiner, T. (2005). Why people die by suicide. Cambridge, MA: Harvard University Press.

44

Joiner, T. (2010). Myths about suicide.Cambridge, MA: Harvard University Press.
Linehan, M. M., Goodstein, J. L., Nielsen, S. L., & Chiles, J. A. (1983). Reasons for staying
alive when you are thinking of killing yourself: The reasons for living inventory.
Journal of Consulting and Clinical Psychology, 51(2), 276-286. doi:10.1037/0022006X.51.2.276
Mayo Foundation for Medical Education and Research (MFMER). (Dec 9, 2008).
Depression. In Antidepressants: Get tips to cope with side effects. Retrieved May 10,
2010 from http://www.mayoclinic.com/health/antidepressants/MH00062
Mishara, B. (World Suicide Prevention Day, Sept. 10, 2009). Suicide prevention:
International efforts and cultural themes United Nations, New York: International
Association for Suicide Prevention. Retrieved on October 17, 2009 from
http://www.iasp.info/wspd/pdf/2009_wspd_president_un_speech.pdf
National Association of Social Workers. (2008). Code of ethics. Washington, D.C.
National Institute of Mental Health. (2009). Suicide in the U.S.: Statistics and Prevention.
Retrieved on October 17, 2009 from
http://www.nimh.nih.gov/health/publications/suicide-in-the-us-statistics-andprevention/index.shtml
Nock, M. K., Borges, G., Bromet, E. J., Cha, C. B., Kessler, R. C., & Lee, S. (2008). Suicide
and suicidal behavior. Epidemiologic Reviews, 30, 133-154.
Nock, M. K., Hwang, I., Sampson, N., Kessler, R. C., Angermeyer, M., Beautrais, A., et al.
(2009) Cross-National Analysis of the Associations among Mental Disorders and
Suicidal Behavior: Findings from the WHO World Mental Health Surveys. PLoS
Med 6(8): e1000123. doi:10.1371/journal.pmed.1000123
45

Placidi, G., Oquendo, M., Malone, K., Brodsky, B., Ellis, S., & Mann, J. (2000). Anxiety in
major depression: relationship to suicide attempts. American Journal of Psychiatry,
157(10), 1614-1618.
Posner, K., Brent, D., Lucas, C., Gould, M., Stanley, B., Brown, G., et al. The Columbia
Suicide Severity Rating Scale. Columbia University; New York, NY: 2008.
Rothman, K. J., & Greenland, S. (Eds.). (1998). Modern epidemiology. Philadelphia:
Lippincott Williams & Wilkins.
Sareen, J., Houlahan, T., Cox, B. J., & Asmundson, G. J. G. (2005). Anxiety disorders
associated with suicidal ideation and suicide attempts in the national comorbidity
survey. Journal of Nervous and Mental Disease, 193(7), 450-454.
doi:10.1097/01.nmd.0000168263.89652.6b
Stein, D. J., Chiu, W.T., Hwang, I., Kessler, R.C., Sampson, N., Alonso, J., et al. (2010)
Cross-National Analysis of the Associations between Traumatic Events and Suicidal
Behavior: Findings from the WHO World Mental Health Surveys. PLoS ONE 5(5):
e10574. doi:10.1371/journal.pone.0010574
Styron, W. (1990). Darkness visible: A memoir of madness. New York: Vintage Books.
U.S. Public Health Service, The Surgeon General's Call To Action To Prevent Suicide.
Washington, DC: 1999. Retrieved October 15, 2009 from
http://mentalhealth.samhsa.gov/suicideprevention/calltoaction.asp
Vickers, K., & McNally, R.J. (2004). Panic disorder and suicide attempt in the National
Comorbidity Survey. Journal of Abnormal Psychology, 113, 582-589.

46

WHO (2008) World Health Organization: Suicide Prevention (SUPRE). Geneva: World
Health Organization. Retrieved October 15, 2009 from
http://www.who.int/mental_health/media/unitstates.pdf
Woolley, S. B., Fredman, L., Goethe, J. W., Lincoln, A. K., & Heeren, T. (2008). Severe
headaches and the risk of suicidal thoughts or behaviors. Journal of Nervous and
Mental Disorders; 196, 822-828.
Yan, J. (2009). Strong link to suicide found for anxiety, conduct disorders
Psychiatric News; 44(18), 28.

47

APPENDIX A

48

APPENDIX B

49

50

51

52

53

